Search

Scientists at Memorial Sloan Kettering are learning how to turn cancer’s appetite against itself.

… Thursday, April 1, 2021 Americans have a love-hate relationship with sugar. Our favorite foods are full of it, yet nutritionists warn that sugar provides empty calories — good for putting on weight but not much else. Cancer doctors are concerned, too, since obesity is a major risk factor for cancer.

Find out how regular screenings with CT scans can help many people who smoke.

… Tuesday, November 10, 2020 Update: On March 9, 2021, the US Preventive Services Task Force (USPSTF) issued new recommendations to expand screening for lung cancer in people who have a history of smoking but no symptoms of the disease. Under the new guidelines, screening is recommended to begin five years

… Wednesday, May 11, 2022 Barbara (“Barb”) Pemberton has a huge smile, an infectious laugh, and a great memory – she vividly remembers how scared she felt when she interviewed to be a phlebotomist in 2004. As she entered the building for the first time, on her way to “stick” someone to demonstrate her

The lack of participation in clinical research may be the Achilles heel facing today’s cancer community. According to a new survey of more than 1,500 consumers and nearly 600 physicians conducted on behalf of MSK, only 35 percent of Americans indicated that they were “likely” to enroll in a clinical trial. For more information or to schedule an interview, please contact [email protected].

… Monday, May 23, 2016 The lack of participation in clinical research may be the Achilles heel facing today’s cancer community.  According to a new survey of more than 1,500 consumers and nearly 600 physicians conducted on behalf of MSK, only 35 percent of Americans indicated that they were “likely” to

New MSK research helped develop a machine-learning tool to help find cancer cells that remain after surgery; led to FDA approval for CAR T cell therapy against mantle cell lymphoma; tested a liquid biopsy approach that shows promise in detecting lung cancer; found checkpoint inhibitors were effective against endometrial and ovarian cancers with DNA-repair deficiency; and shed new light on mTOR's role in metabolic enzyme degradation.

… Tuesday, June 25, 2024 New research from Memorial Sloan Kettering Cancer Center (MSK) helped develop a machine-learning tool to help find cancer cells that remain after surgery; led to Food and Drug Administration approval for CAR T cell therapy against mantle cell lymphoma; tested a liquid biopsy approach

Part natural killer, part T cell, this hybrid immune cell has a “double sword” for fighting cancer.

… Tuesday, October 5, 2021 Pick up any immunology textbook and you’ll find an explanation of the “innate” and “adaptive” arms of the immune system. The innate arm is active from birth and responds to a predefined set of common threats; the adaptive arm takes time to develop but is more versatile at combatting

The new Fiona and Stanley Druckenmiller Center for Lung Cancer Research brings together MSK physicians and scientists in an intensive, multidisciplinary effort against the number-one cause of death from cancer in the nation.

… Friday, January 8, 2016 Summary Lung cancer causes more deaths in the United States than colon, breast, and prostate cancers combined. The Druckenmiller Center gathers scientists and physicians from across MSK to advance our understanding of the disease, examine novel treatments in preclinical models

Surgical resection of symptomatic, benign intradural extramedullary (IDEM) spine tumors provides rapid, significant, and durable improvements in patient-reported outcomes.

… Tuesday, March 2, 2021 Surgical resection of symptomatic, benign intradural extramedullary (IDEM) spine tumors provides rapid, significant, and durable improvements in patient-reported outcomes (PROs), according to our study published recently in Neurosurgery .   (1) Historically, these tumors have been

Chris Bourne is the first recipient of the MERIT Sawyers Fellowship.

… Thursday, February 10, 2022 Chris Bourne remembers the moment he knew he wanted to become a researcher. He had just completed freshman year at Swarthmore College in Pennsylvania and landed a summer internship with a pharmaceutical company near where he had grown up in South Brunswick, New Jersey. “I’

Breast conservation therapy as an initial treatment did not compromise survival outcomes compared to mastectomy in breast cancer patients under the age of 35.

… Thursday, January 14, 2021 Survival outcomes in breast cancer patients under the age of 35 was not compromised in those who had initial conservation therapy versus those who had mastectomy, according to our retrospective study published recently in the International Journal of Radiation Oncology .  (